A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury
Autor: | Jiao Jing Wang, Sarah A. Taylor, Zheng J. Zhang, Kyle D. Gromer, Xin Yi Yeap, Alyssa Kriegermeier, Richard M. Green |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Physiology medicine.drug_class 030204 cardiovascular system & hematology digestive system Gastroenterology lcsh:Physiology Bile Acids and Salts Mice 03 medical and health sciences 0302 clinical medicine Immune system Cholestasis Physiology (medical) Internal medicine medicine Animals ABCB11 Ligation ATP Binding Cassette Transporter Subfamily B Member 11 Original Research Liver injury biliary obstruction lcsh:QP1-981 Bile acid Bile duct business.industry Liver Diseases medicine.disease Bile duct proliferation macrophages Disease Models Animal medicine.anatomical_structure liver repair Duodenum cholestasis business Biomarkers 030217 neurology & neurosurgery liver injury |
Zdroj: | Physiological Reports, Vol 8, Iss 10, Pp n/a-n/a (2020) Physiological Reports |
ISSN: | 2051-817X |
DOI: | 10.14814/phy2.14446 |
Popis: | There are limited murine models of cholestatic liver diseases characterized by chronic biliary obstruction and resumption of bile flow. While murine bile duct ligation (BDL) is a well‐established model of obstructive cholestasis, current models of BDL reversal (BDLR) alter biliary anatomy. We aimed to develop a more physiologic model of BDLR to evaluate the time course and mechanism for resolution of hepatic injury after biliary obstruction. In the present study, we restored bile flow into the duodenum without disruption of the gall bladder after murine BDL using biocompatible PE‐50 tubing. After establishing the technique, overall survival for BDLR at 7 or 14 days after BDL was 88%. Sham laparotomy was performed in control mice. Laboratory data, liver histology, and hepatic gene expression were compared among BDL, BDLR, and controls. Laboratory evidence of cholestatic liver injury was observed at day 7 after BDL and rapid improvement occurred within 48 hr of BDLR. After BDLR there was also enhanced gene expression for the bile acid transporter Abcb11, however, bile duct proliferation persisted. Assessment of the immune response showed increased gene and protein expression for the general immune cell marker Cd45 in BDLR versus BDL mice suggesting a reparative immune response after BDLR. In summary, we have established a novel murine model of BDLR that allows for the investigation into bile acid and immune pathways responsible for hepatic repair following obstructive cholestasis. Future studies with our model may identify targets for new therapies to improve outcome in pediatric and adult cholestatic liver disease. We have established a novel surgical murine model of reversible bile duct ligation that is more physiologic than prior models of bile duct ligation reversal. Our model demonstrates acute hepatic injury from 7‐day bile duct ligation with rapid improvement after restoration of bile flow, including changes in immune, bile acid, and fibrotic pathways during this response. Further studies with this model may identify novel therapeutic targets for pediatric and adult cholestatic liver disease. |
Databáze: | OpenAIRE |
Externí odkaz: |